this page is secure

The significance of pretreatment anemia in the era of R‐IPI and NCCN‐IPI prognostic risk assessment tools: a dual‐center study in diffuse large B‐cell lymphoma patients

Buy Article:

Authors: Troppan, Katharina T.; Melchardt, Thomas; Deutsch, Alexander; Schlick, Konstantin; Stojakovic, Tatjana; Bullock, Marc D.; Reitz, Daniel; Beham‐Schmid, Christine; Weiss, Lukas; Neureiter, Daniel; Wenzl, Kerstin; Greil, Richard; Neumeister, Peter; Egle, Alexander; Pichler, Martin

Source: European Journal of Haematology, Volume 95, Number 6, 1 December 2015, pp. 538-544(7)

Publisher: Wiley-Blackwell

DOI: https://doi.org/10.1111/ejh.12529

Anemia is frequently identified at the time of diagnosis in patients with diffuse large B‐cell lymphoma (DLBCL); however, studies addressing the prognostic significance of this important clinical parameter are lacking.

No References

No Citations

No Supplementary Data

No Article Media

No Metrics

Keywords: diffuse large B‐cell lymphoma; hemoglobin; prognostic factors

Document Type: Research Article

Publication date: December 1, 2015

Access Key
Free content
Partial Free content
New content
Open access content
Partial Open access content
Subscribed content
Partial Subscribed content
Free trial content

The significance of pretreatment anemia in the era of R‐IPI and NCCN‐IPI prognostic risk assessment tools: a dual‐center study in diffuse large B‐cell lymphoma patients

Buy Article:

Sign-in

Tools

Share Content

Cookie Policy